
Prof Chris P Gale
@cpgale3
Professor of Cardiovascular Medicine, Honorary Consultant Cardiologist. Specialist adult cardiovascular care: putting research into practice to benefit patients
ID: 760436883734147073
https://www.circlehealthgroup.co.uk/consultants/chris-gale 02-08-2016 11:27:36
17,17K Tweet
13,13K Followers
1,1K Following



Now 7000 steps per day… The Lancet Public Health thelancet.com/journals/lanpu…





In this meta-analysis of 8 RCTs of 3009 patients aged >= 70 yrs with ACS comparing early invasive strategy with conservative management, there was no difference in death, but it reduced #heartattack & repeat revascularisation with increased major bleeding. jamanetwork.com/journals/jamai…


Our British Heart Foundation funded #FINDAF research will be presented in the Late-Breaking Clinical Trials session European Society of Cardiology 2025 Congress, Madrid on 30th August at 11:45 am. Well done Ramesh Nadarajah & team Cardio-Respiratory - LTHT Leeds Research & Innovation Leeds Teaching Hospitals LICAMM NIHR CRN Yorkshire & Humber #AFib #AI


🤔, will humans be able to adapt to increasing heat? Nature Medicine share.google/VZJbi4SNG9MpEe…




📢 Presenting our The Lancet Reg Health-Europe Series on CVD Inequalities at #ESCCongress Madrid! 📍 Fri Aug 29 | 13:45–15:00 | Room Zagreb 📰 Simultaneous publication in The Lancet Reg Health-Europe A big step toward closing the heart health gap! European Society of Cardiology Raffaele Bugiardini Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Prof Chris P Gale


Our The Lancet Reg Health-Europe series… #cardiovascular #inequalities #ESCcongress


In this subanalyses of the DAPA‐MI RCT, we found that Dapagliflozin reduced new-onset T2DM following #heartattack, regardless of baseline HbA1c or BMI, & provided greater reduction in #heartfailure symptom burden in prediabetes compared with normoglycemia. ahajournals.org/doi/10.1161/JA…